Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Li-Fraumeni Syndrome 1Glioma 1Glioblastoma 1

Interventions

Specimen Handling 642pembrolizumab 565Magnetic Resonance Spectroscopy 548Carboplatin 426Cisplatin 377Cyclophosphamide 374Biopsy 365Paclitaxel 306Nivolumab 303Gemcitabine 303Radiotherapy 274Bevacizumab 240Dexamethasone 209fludarabine 207Docetaxel 191durvalumab 183atezolizumab 177Oxaliplatin 174venetoclax 168Fluorouracil 167Rituximab 166Pemetrexed 164Capecitabine 161Radiation 159Doxorubicin 159Radiosurgery 150Etoposide 137Ipilimumab 135Leucovorin 133Lenalidomide 132

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Diffusion Magnetic Resonance Imaging × 90 days × Clear all
NCT03176836 2026-04-29

Li-Fraumeni Syndrome Imaging Study

The Hospital for Sick Children

Phase NA Enrolling by invitation
30 enrolled

Li-Fraumeni Syndrome

NCT07532031 2026-04-15

APT-HGG

IRCCS Ospedale San Raffaele

Not yet recruiting
20 enrolled
CNS

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡